{"id":"zolpidem-hemitartrate","safety":{"commonSideEffects":[{"rate":"5-10%","effect":"Dizziness"},{"rate":"5-10%","effect":"Drowsiness/somnolence"},{"rate":"5-10%","effect":"Headache"},{"rate":"1-5%","effect":"Amnesia/memory impairment"},{"rate":"1-2%","effect":"Complex sleep behaviors"},{"rate":"variable with duration","effect":"Dependence/tolerance"}]},"_chembl":{"chemblId":"CHEMBL3989820","moleculeType":"Small molecule","molecularWeight":"764.88"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Zolpidem is a non-benzodiazepine hypnotic (Z-drug) that selectively binds to alpha-1 subunit-containing GABA-A receptors, particularly in the brain regions responsible for sleep regulation. By enhancing the inhibitory effects of GABA, it reduces neuronal excitability and facilitates the transition to sleep. The hemitartrate salt form is used to improve the drug's solubility and bioavailability.","oneSentence":"Zolpidem hemitartrate is a sedative-hypnotic that binds to GABA-A receptors in the brain to enhance inhibitory neurotransmission and promote sleep onset.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:16:43.944Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Insomnia (short-term treatment of sleep initiation difficulty)"}]},"trialDetails":[{"nctId":"NCT05540574","phase":"PHASE2","title":"Trial of Zolpidem for Sleep in Children With Autism","status":"RECRUITING","sponsor":"Stanford University","startDate":"2023-08-09","conditions":"Autism, Autism Spectrum Disorder","enrollment":26},{"nctId":"NCT04118387","phase":"PHASE4","title":"Central Sleep Apnea : Physiologic Mechanisms to Inform Treatment","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2021-01-07","conditions":"Sleep Disordered Breathing, Able Bodied","enrollment":200},{"nctId":"NCT07336277","phase":"PHASE3","title":"Sleep Quality and the Efficacy of a Multimodal Sleep Pathway in Hospitalized Orthopedic Trauma Patients","status":"NOT_YET_RECRUITING","sponsor":"Emory University","startDate":"2026-03","conditions":"Orthopedic Trauma, Sleep Quality","enrollment":30},{"nctId":"NCT04014387","phase":"PHASE4","title":"Treatment of Disturbed Sleep in Progressive Supranuclear Palsy (PSP)","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2019-06-02","conditions":"Treatment","enrollment":40},{"nctId":"NCT06975514","phase":"PHASE3","title":"Safety and Efficacy Study of YZJ-1139 Tablets in Insomnia Disorder","status":"RECRUITING","sponsor":"Shanghai Haiyan Pharmaceutical Technology Co., Ltd.","startDate":"2025-03-25","conditions":"Insomnia Disorder","enrollment":60},{"nctId":"NCT03774810","phase":"PHASE4","title":"Partial Reinforcement II: Three Approaches to Maintenance Therapy for Chronic Insomnia","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2019-04-15","conditions":"Insomnia, Insomnia Chronic","enrollment":197},{"nctId":"NCT03375203","phase":"PHASE2","title":"A Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-42847922 in Participants With Insomnia Disorder","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2017-11-23","conditions":"Insomnia Disorders","enrollment":365},{"nctId":"NCT06640023","phase":"NA","title":"The Study in Outpatient Medicine Using Nudges to Improve Sleep","status":"ENROLLING_BY_INVITATION","sponsor":"University of Southern California","startDate":"2024-12-20","conditions":"Inappropriate Prescribing","enrollment":443},{"nctId":"NCT05106153","phase":"PHASE1","title":"A Study to Determine the Abuse Potential of Seltorexant Compared to Suvorexant and Zolpidem","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2021-12-17","conditions":"Healthy Non-dependent, Recreational Sedative Users, Abuse Potential","enrollment":127},{"nctId":"NCT04273776","phase":"EARLY_PHASE1","title":"A Comparison of the Physiological and Behavioral Effects of Suvorexant and Zolpidem in Healthy Volunteers: A Randomized, Double-blind, Placebo Controlled Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Walter Reed Army Institute of Research (WRAIR)","startDate":"2019-12-01","conditions":"Performance Enhancing Product Use","enrollment":90},{"nctId":"NCT05351541","phase":"PHASE1, PHASE2","title":"Psilocybin Therapy for Chronic Low Back Pain","status":"RECRUITING","sponsor":"Joshua Woolley, MD, PhD","startDate":"2023-12-01","conditions":"Chronic Low-back Pain","enrollment":30},{"nctId":"NCT04278404","phase":"","title":"Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)","status":"RECRUITING","sponsor":"Duke University","startDate":"2020-03-05","conditions":"Coronavirus Infection (COVID-19), Pulmonary Arterial Hypertension, Urinary Tract Infections in Children","enrollment":5000},{"nctId":"NCT04468776","phase":"PHASE4","title":"CBT-I or Zolpidem/Trazodone for Insomnia","status":"COMPLETED","sponsor":"California Pacific Medical Center Research Institute","startDate":"2022-02-25","conditions":"Chronic Insomnia","enrollment":155},{"nctId":"NCT06740188","phase":"PHASE4","title":"Trazodone on NREM Sleep Stage Ⅲ in Depressed Insomniac Co-morbid Patients","status":"RECRUITING","sponsor":"Tongji University","startDate":"2025-01-01","conditions":"Depressed Insomniac Co-morbid Patients","enrollment":60},{"nctId":"NCT03436745","phase":"PHASE1","title":"The Effects of Castration on the Pharmacokinetics of Zolpidem After Single Dose Administration In Men With Prostate Cancer Undergoing Androgen Deprivation Therapy Compared to Normal Healthy Females","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2019-01-22","conditions":"Prostatic Neoplasms","enrollment":12},{"nctId":"NCT03657212","phase":"PHASE4","title":"Enhancing Memory Consolidation in Older Adults","status":"TERMINATED","sponsor":"University of California, Irvine","startDate":"2018-10-01","conditions":"Aging","enrollment":10},{"nctId":"NCT06800378","phase":"PHASE4","title":"Zolpidem's Effects on Road Cycling Performance","status":"COMPLETED","sponsor":"National Taiwan Normal University","startDate":"2024-06-26","conditions":"Healthy","enrollment":15},{"nctId":"NCT06512155","phase":"PHASE1","title":"Improving Perioperative Sleep Disorders","status":"COMPLETED","sponsor":"Mengchang Yang","startDate":"2024-07-02","conditions":"Sleep Disorder","enrollment":215},{"nctId":"NCT02783729","phase":"PHASE3","title":"Study of the Efficacy and Safety of Lemborexant in Subjects 55 Years and Older With Insomnia Disorder (SUNRISE 1)","status":"COMPLETED","sponsor":"Eisai Inc.","startDate":"2016-05-31","conditions":"Insomnia","enrollment":1006},{"nctId":"NCT06685341","phase":"PHASE1","title":"PK/PD Study of YZJ-1139","status":"COMPLETED","sponsor":"Shanghai Haiyan Pharmaceutical Technology Co., Ltd.","startDate":"2019-03-07","conditions":"Insomnia","enrollment":20},{"nctId":"NCT00833521","phase":"PHASE1","title":"Zolpidem Tartrate 10 mg Tablets Under Fasting Conditions","status":"COMPLETED","sponsor":"Teva Pharmaceuticals USA","startDate":"2002-02","conditions":"Healthy","enrollment":38},{"nctId":"NCT00833937","phase":"PHASE1","title":"Zolpidem Tartrate 10 mg Tablets Under Non-Fasting Conditions","status":"COMPLETED","sponsor":"Teva Pharmaceuticals USA","startDate":"2002-03","conditions":"Healthy","enrollment":24},{"nctId":"NCT05746143","phase":"PHASE4","title":"The Effect of Zolpidem on Outcomes Following Lumbar Spine Fusion","status":"RECRUITING","sponsor":"University of Southern California","startDate":"2022-02-01","conditions":"Spine Fusion, Lumbar Spine Degeneration, Pain, Postoperative","enrollment":140},{"nctId":"NCT03338764","phase":"PHASE3","title":"An Investigational Study to Assess Efficacy and Pattern of Use of SM-1 in Subjects With a History of Transient Insomnia","status":"WITHDRAWN","sponsor":"Sequential Medicine Ltd","startDate":"2023-05","conditions":"Transient Insomnia","enrollment":""},{"nctId":"NCT02456532","phase":"PHASE4","title":"Safety and Efficacy of Chronic Hypnotic Use 2","status":"COMPLETED","sponsor":"Henry Ford Health System","startDate":"2015-08-05","conditions":"Chronic Insomnia","enrollment":41},{"nctId":"NCT06303076","phase":"PHASE4","title":"Tizanidine vs. Zolpidem in Primary Insomnia: A Randomized Trial","status":"NOT_YET_RECRUITING","sponsor":"Sultan Qaboos University","startDate":"2024-09","conditions":"Depressive Disorder, Major","enrollment":90},{"nctId":"NCT06244277","phase":"NA","title":"Chinese Medicine Treatment of Adolescent Sleep Disorders and Sleeping Pills Withdrawal","status":"UNKNOWN","sponsor":"The First Affiliated Hospital with Nanjing Medical University","startDate":"2023-12-22","conditions":"Traditional Chinese Medicine, Sleep Disorder","enrollment":106},{"nctId":"NCT04720547","phase":"PHASE4","title":"Sleep and Breathing in the General Population - Chemical Stimuli","status":"COMPLETED","sponsor":"Wayne State University","startDate":"2018-07-03","conditions":"Sleep-disordered Breathing","enrollment":14},{"nctId":"NCT04692285","phase":"PHASE1","title":"Electrophysiological and Neuroimaging Correlates of the Effect of Zolpidem in Patients With Focal Dystonia","status":"COMPLETED","sponsor":"University Medical Centre Ljubljana","startDate":"2017-09-30","conditions":"Focal Dystonia","enrollment":24},{"nctId":"NCT06084130","phase":"PHASE4","title":"Zolpidem on CPAP Acclimatization in OSA","status":"UNKNOWN","sponsor":"Siriraj Hospital","startDate":"2023-10-15","conditions":"Obstructive Sleep Apnea","enrollment":30},{"nctId":"NCT05456152","phase":"PHASE3","title":"Safety and Efficacy of Zolpidem in the Long-Term Treatment of Insomnia","status":"UNKNOWN","sponsor":"EMS","startDate":"2024-06","conditions":"Chronic Insomnia","enrollment":358},{"nctId":"NCT01431326","phase":"","title":"Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care","status":"COMPLETED","sponsor":"Daniel Benjamin","startDate":"2011-11","conditions":"Adenovirus, Anesthesia, Anxiety","enrollment":3520},{"nctId":"NCT05764798","phase":"PHASE1","title":"Shugan Jieyu Capsule for Insomnia Patients With Depressive Symptoms","status":"UNKNOWN","sponsor":"Nanfang Hospital, Southern Medical University","startDate":"2022-11-30","conditions":"Insomnia","enrollment":60},{"nctId":"NCT05615727","phase":"PHASE3","title":"Intranasal Dexmedetomidine and Zolpidem for Treatment of Primary Insomnia","status":"UNKNOWN","sponsor":"The University of Hong Kong","startDate":"2022-09-01","conditions":"Insomnia","enrollment":20},{"nctId":"NCT05521971","phase":"NA","title":"The Impact of a Pharmacist Intervention on Post-discharge Hypnotic Drug Discontinuation in Geriatric Inpatients","status":"COMPLETED","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2016-10-11","conditions":"Hypnotic Withdrawal","enrollment":173},{"nctId":"NCT02948660","phase":"PHASE2","title":"A Promising Tool for Predicting Consciousness Evolution in Prolonged Disorders of Consciousness","status":"COMPLETED","sponsor":"Xijing Hospital","startDate":"2017-12-01","conditions":"Disorder of Consciousness","enrollment":36},{"nctId":"NCT01689909","phase":"PHASE4","title":"Reducing Suicidal Ideation Through Insomnia Treatment","status":"COMPLETED","sponsor":"Augusta University","startDate":"2012-12-06","conditions":"Insomnia, Depression, Suicidal Ideation","enrollment":103},{"nctId":"NCT03584542","phase":"","title":"ZOlpidem and the stRengthening of pRescription regulatiOn","status":"COMPLETED","sponsor":"Nantes University Hospital","startDate":"2018-07-25","conditions":"Substance Use Disorders","enrollment":449},{"nctId":"NCT00777829","phase":"NA","title":"Memory Consolidation in Pharmacologically Enhanced Naps","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2008-09-01","conditions":"Sleep","enrollment":30},{"nctId":"NCT01030874","phase":"NA","title":"Orthostatic Hypotension Treatment on Rehab Unit","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2011-10","conditions":"Orthostatic Hypotension, Falls","enrollment":356},{"nctId":"NCT04009577","phase":"PHASE3","title":"A Study to Evaluate Next-Dose Transition From Zolpidem to Lemborexant (LEM) for the Treatment of Insomnia","status":"COMPLETED","sponsor":"Eisai Inc.","startDate":"2019-07-15","conditions":"Insomnia","enrollment":53},{"nctId":"NCT01651442","phase":"NA","title":"Sequenced Therapies for Comorbid and Primary Insomnias","status":"COMPLETED","sponsor":"Jack Edinger, PhD","startDate":"2012-08-01","conditions":"Insomnia Comorbid to Psychiatric Disorder, Primary Insomnia","enrollment":211},{"nctId":"NCT04102345","phase":"EARLY_PHASE1","title":"Lavender vs Zolpidem Sleep Quality During Diagnostic PSG","status":"COMPLETED","sponsor":"HealthPartners Institute","startDate":"2019-09-04","conditions":"Sleep","enrollment":58},{"nctId":"NCT03160404","phase":"EARLY_PHASE1","title":"Zolpidem or Exercise for Insomnia?","status":"COMPLETED","sponsor":"Universidade Federal de Goias","startDate":"2018-04-16","conditions":"Chronic Insomnia","enrollment":34},{"nctId":"NCT01896336","phase":"PHASE4","title":"Efficacy and Safety of 5 mg Sublingual Zolpidem vs 10mg Oral Zolpidem in the Induction and Maintenance of Sleep in Patients With Primary Insomnia","status":"COMPLETED","sponsor":"EMS","startDate":"2013-02-18","conditions":"Primary Insomnia","enrollment":67},{"nctId":"NCT03075241","phase":"PHASE3","title":"Z-Drugs for Sleep Disorders in Alzheimer's Disease","status":"COMPLETED","sponsor":"Brasilia University Hospital","startDate":"2016-10","conditions":"Sleep, Sleep Disorders, Insomnia","enrollment":62},{"nctId":"NCT03885141","phase":"PHASE2, PHASE3","title":"Biolab Zolpidem Orodispersible 1.0 mg, 1.75 mg and 3.5 mg to Treat Maintenance Insomnia Disorder.","status":"UNKNOWN","sponsor":"Biolab Sanus Farmaceutica","startDate":"2021-03","conditions":"Insomnia Disorder","enrollment":366},{"nctId":"NCT03158025","phase":"PHASE1","title":"A Study to Determine the Abuse Potential of Single Oral Doses of Lemborexant Compared to Zolpidem, Suvorexant and Placebo in Healthy, Non-Dependent, Recreational Sedative Users","status":"COMPLETED","sponsor":"Eisai Inc.","startDate":"2017-04-19","conditions":"Insomnia Disorders","enrollment":39},{"nctId":"NCT03269760","phase":"PHASE1","title":"Multimodal Sleep Pathway for Shoulder Arthroplasty","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2017-09-01","conditions":"Sleep Disturbance, Shoulder Arthritis, Arthroplasty Complications","enrollment":122},{"nctId":"NCT04396327","phase":"PHASE2","title":"SM-1 vs. an Active Comparator in A Model of Transient Insomnia","status":"NOT_YET_RECRUITING","sponsor":"Sequential Medicine Ltd","startDate":"2020-05-27","conditions":"Transient Insomnia","enrollment":14},{"nctId":"NCT02839200","phase":"PHASE2","title":"Efficacy and Safety of ACT-541468 in Adult Subjects With Insomnia Disorder","status":"COMPLETED","sponsor":"Idorsia Pharmaceuticals Ltd.","startDate":"2016-10-04","conditions":"Insomnia Disorder","enrollment":360},{"nctId":"NCT03621046","phase":"PHASE2","title":"Use of Low-dose Zolpidem in Parkinson's Disease","status":"COMPLETED","sponsor":"Aston University","startDate":"2018-08-20","conditions":"Parkinson Disease","enrollment":28},{"nctId":"NCT03307005","phase":"PHASE4","title":"Improving Sleep Quality in Heart Failure","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2017-11-01","conditions":"Sleep Disturbance, Heart Failure","enrollment":5},{"nctId":"NCT03297944","phase":"PHASE4","title":"Sedative-Anxiolytic Effects on Simulated Driving Performance","status":"COMPLETED","sponsor":"Marion Coe","startDate":"2017-09-15","conditions":"Psychomotor Impairment","enrollment":15},{"nctId":"NCT01463098","phase":"PHASE1","title":"A 2-Part Single Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2006","status":"COMPLETED","sponsor":"Eisai Inc.","startDate":"2011-10-05","conditions":"Insomnia","enrollment":122},{"nctId":"NCT01485393","phase":"NA","title":"Polysomnographic Study Comparing the Use of Dexmedetomidine and Zolpidem to Induce Natural Sleep","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2015-01","conditions":"Insomnia","enrollment":10},{"nctId":"NCT03657355","phase":"PHASE1","title":"Study to Evaluate the Abuse Potential of ACT-541468 in Healthy Recreational Drug Users","status":"COMPLETED","sponsor":"Idorsia Pharmaceuticals Ltd.","startDate":"2018-09-07","conditions":"Healthy Recreational Drug Users","enrollment":63},{"nctId":"NCT03008447","phase":"PHASE1","title":"Crossover Study to Evaluate the Effect of Lemborexant Versus Placebo and Zolpidem on Postural Stability, Auditory Awakening Threshold, and Cognitive Performance in Healthy Subjects 55 Years and Older","status":"COMPLETED","sponsor":"Eisai Inc.","startDate":"2016-11-21","conditions":"Healthy Subjects","enrollment":60},{"nctId":"NCT03056053","phase":"PHASE2","title":"Study to Validate the Questionnaire Called IDSIQ™ in Patients With Insomnia Disorder","status":"COMPLETED","sponsor":"Idorsia Pharmaceuticals Ltd.","startDate":"2017-02-15","conditions":"Insomnia Disorder","enrollment":113},{"nctId":"NCT03331042","phase":"PHASE3","title":"SM-1 vs 2 Comparators and Placebo in Participants With a History of Transient Insomnia.","status":"COMPLETED","sponsor":"Sequential Medicine Ltd","startDate":"2017-10-09","conditions":"Transient Insomnia","enrollment":85},{"nctId":"NCT01685073","phase":"PHASE2, PHASE3","title":"The Role of Sleep in the Treatment of Cannabis Use Disorders","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2012-09","conditions":"Drug Addiction","enrollment":127},{"nctId":"NCT02033707","phase":"PHASE1","title":"Effects of Hallucinogens and Other Drugs on Mood and Performance","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2014-04","conditions":"Healthy","enrollment":20},{"nctId":"NCT03786120","phase":"","title":"The Efficacy of Lower Dose Zolpidem for Achieving Satisfactory Sleep in Women With Disordered Sleep","status":"UNKNOWN","sponsor":"Rhode Island Hospital","startDate":"2019-01-31","conditions":"Sleep Disorder","enrollment":50},{"nctId":"NCT02096900","phase":"PHASE3","title":"A Comparison of Midazolam and Zolpidem as Oral Premedication in Children","status":"COMPLETED","sponsor":"Loma Linda University","startDate":"2014-07-21","conditions":"Parental/Caregiver Anxiety, Child's Anxiety","enrollment":86},{"nctId":"NCT00939367","phase":"PHASE1","title":"Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Zolpidem Tartrate Tablets Under Fed Conditions","status":"COMPLETED","sponsor":"Torrent Pharmaceuticals Limited","startDate":"2007-02-24","conditions":"Healthy","enrollment":50},{"nctId":"NCT02817750","phase":"PHASE1","title":"Pharmacokinetics Study of Zolpidem Hemitartarate Orodispersible Tablet 3.5 mg Formulation","status":"COMPLETED","sponsor":"Biolab Sanus Farmaceutica","startDate":"2017-07-05","conditions":"Healthy","enrollment":28},{"nctId":"NCT02814058","phase":"PHASE1","title":"Pharmacokinetics Study of Zolpidem Hemitartarate Orodispersible Tablet 1.75 mg Formulation","status":"COMPLETED","sponsor":"Biolab Sanus Farmaceutica","startDate":"2017-07-05","conditions":"Healthy","enrollment":28},{"nctId":"NCT02484963","phase":"NA","title":"The Study of Spectrum of Sleep Disorders in Cirrhotic Patients and the Efficacy of Zolpidem in Cirrhotic Patients With Insomnia","status":"COMPLETED","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2015-05-15","conditions":"Cirrhosis","enrollment":52},{"nctId":"NCT03526575","phase":"PHASE4","title":"Optimize Astronaut Sleep Medication Efficacy and Individual Effects","status":"COMPLETED","sponsor":"National Aeronautics and Space Administration (NASA)","startDate":"2011-01-10","conditions":"Sleep, Cognition, Pharmacologic Actions","enrollment":34},{"nctId":"NCT02139098","phase":"PHASE3","title":"Alternative Dosing Regimens in the Pharmacotherapy of Insomnia","status":"TERMINATED","sponsor":"Philipps University Marburg","startDate":"2014-05","conditions":"Insomnia","enrollment":23},{"nctId":"NCT02671760","phase":"PHASE2","title":"Pilot Study of a Combination Drug Product for Treatment of Short-term Insomnia","status":"COMPLETED","sponsor":"Sequential Medicine Ltd","startDate":"2016-02","conditions":"Short-term Insomnia","enrollment":39},{"nctId":"NCT02374567","phase":"PHASE3","title":"Pharmacovigilance in Gerontopsychiatric Patients","status":"TERMINATED","sponsor":"Hannover Medical School","startDate":"2015-01","conditions":"Dementia, Depression, Schizophrenia","enrollment":407},{"nctId":"NCT00602719","phase":"NA","title":"Bioequivalency Study of Zolpidem Tartrate Under Fed Conditions","status":"COMPLETED","sponsor":"Roxane Laboratories","startDate":"2004-03","conditions":"Insomnia","enrollment":30},{"nctId":"NCT00601666","phase":"NA","title":"Bioequivalency Study of Zolpidem Tartrate Under Fasting Conditions","status":"COMPLETED","sponsor":"Roxane Laboratories","startDate":"2004-03","conditions":"Insomnia","enrollment":30},{"nctId":"NCT02778659","phase":"NA","title":"Hypnotic Intake and Motor and Cognitive Performances at High Altitude","status":"COMPLETED","sponsor":"Centre d'Expertise sur l'Altitude EXALT","startDate":"2016-05","conditions":"Physiology","enrollment":22},{"nctId":"NCT02353299","phase":"PHASE4","title":"Assess the Effect of Zolpidem, Silenor & Placebo on Arousability, Ataxia/Balance & Cognition in Healthy Volunteers","status":"COMPLETED","sponsor":"Currax Pharmaceuticals","startDate":"2015-01","conditions":"Healthy","enrollment":52},{"nctId":"NCT00440323","phase":"PHASE1","title":"Disturbed Sleep Model Study.","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2007-01-05","conditions":"Sleep Initiation and Maintenance Disorders","enrollment":52},{"nctId":"NCT00662155","phase":"NA","title":"The Role of Partial Reinforcement in the Long Term Management of Insomnia","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2006-07","conditions":"Primary Insomnia","enrollment":129},{"nctId":"NCT00976105","phase":"PHASE1","title":"Effects of Repeat Dosing of GSK1521498","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2009-09-22","conditions":"Obesity","enrollment":49},{"nctId":"NCT00383643","phase":"PHASE2","title":"Xyrem(Sodium Oxybate) and Ambien(Zolpidem Tartrate) in the Treatment of Chronic Insomnia.","status":"COMPLETED","sponsor":"Stanford University","startDate":"2006-05","conditions":"Sleep Initiation and Maintenance Disorders","enrollment":48},{"nctId":"NCT00676026","phase":"NA","title":"Impact of GABA-Enhancing Agents on Cortical GABA Concentrations Across the Menstrual Cycle in Women","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2005-05","conditions":"Healthy","enrollment":8},{"nctId":"NCT00814502","phase":"NA","title":"Zolpidem CR and Hospitalized Patients With Dementia","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2008-12","conditions":"Dementia, Alzheimer Disease, Dementia, Vascular","enrollment":20},{"nctId":"NCT01804036","phase":"PHASE2, PHASE3","title":"Two Contrasting Interventions for Sleep Management","status":"COMPLETED","sponsor":"University of Utah","startDate":"2013-03","conditions":"Primary Insomnia, Secondary Insomnia","enrollment":72},{"nctId":"NCT00653562","phase":"PHASE4","title":"Zolpidem (Myslee) Post Marketing Study in Adolescent Patients With Insomnia - Evaluation With Polysomnography","status":"COMPLETED","sponsor":"Astellas Pharma Inc","startDate":"2006-11","conditions":"Insomnia, Sleep Initiation and Maintenance Disorders","enrollment":11},{"nctId":"NCT00432198","phase":"PHASE4","title":"Zolpidem Postmarketing Study in Adolescent Patients With Insomnia","status":"COMPLETED","sponsor":"Astellas Pharma Inc","startDate":"2007-02","conditions":"Insomnia","enrollment":122},{"nctId":"NCT02607696","phase":"PHASE1","title":"Pharmacokinetics of Zolpidem Orodispersible Tablet","status":"WITHDRAWN","sponsor":"Biolab Sanus Farmaceutica","startDate":"2016-05","conditions":"Healthy Volunteers","enrollment":""},{"nctId":"NCT00539110","phase":"PHASE2","title":"Differential Effects of Zolpidem Versus Ramelteon in Burned Children","status":"COMPLETED","sponsor":"Shriners Hospitals for Children","startDate":"2009-12","conditions":"Sleep, Burns","enrollment":10},{"nctId":"NCT00177216","phase":"PHASE4","title":"Characteristics of Sleep Patterns in Young Adults With and Without Insomnia","status":"COMPLETED","sponsor":"University of Pittsburgh","startDate":"2002-02","conditions":"Sleep Disorders","enrollment":69},{"nctId":"NCT02578472","phase":"PHASE1","title":"Pilot Study to Evaluate the Duration of Effects on Simulated Car Driving and Cognitive Performance After a Single Dose of JNJ-42847922, Zolpidem and Placebo in Healthy Participants","status":"COMPLETED","sponsor":"Janssen-Cilag International NV","startDate":"2015-11","conditions":"Healthy","enrollment":36},{"nctId":"NCT00608985","phase":"PHASE3","title":"Almorexant (ACT 078573) in Adult Subjects With Chronic Primary Insomnia","status":"COMPLETED","sponsor":"Midnight Pharma, LLC","startDate":"2008-03","conditions":"Primary Insomnia","enrollment":709},{"nctId":"NCT00781482","phase":"PHASE4","title":"Positron Emission Tomography Assessment of the Central Nervous System Effects of Eszopiclone and Zolpidem","status":"WITHDRAWN","sponsor":"Kettering Health Network","startDate":"","conditions":"Healthy","enrollment":""},{"nctId":"NCT01987739","phase":"PHASE1","title":"Study to Evaluate the Relative Abuse Potential of Almorexant in Recreational Drug Users","status":"COMPLETED","sponsor":"Midnight Pharma, LLC","startDate":"2009-09","conditions":"Abuse Potential Study","enrollment":42},{"nctId":"NCT02648776","phase":"","title":"Risk and Benefit Assessment of Hypnotic Agents for Sleep Disorders Among Elderly","status":"UNKNOWN","sponsor":"China Medical University Hospital","startDate":"2016-01","conditions":"Sleep Disorders","enrollment":1400},{"nctId":"NCT00156533","phase":"PHASE4","title":"Long Term Treatment With Zolpidem: Nightly and Intermittent Dosing","status":"COMPLETED","sponsor":"University of Rochester","startDate":"2005-03","conditions":"Insomnia, Primary Insomnia, Psychophysiologic Insomnia","enrollment":20},{"nctId":"NCT01071889","phase":"PHASE1, PHASE2","title":"Safety and the Efficacy of a Sublingual Administration of Flumazenil to Reverse the Effect of Hypnotic Drugs in Healthy Adults","status":"COMPLETED","sponsor":"Coeruleus Ltd.","startDate":"2010-05","conditions":"Healthy","enrollment":10},{"nctId":"NCT01243060","phase":"NA","title":"Effect of a Hypocretin/Orexin Antagonist on Neurocognitive Performance","status":"COMPLETED","sponsor":"Northern California Institute of Research and Education","startDate":"2011-05","conditions":"Healthy Volunteers","enrollment":203},{"nctId":"NCT01181232","phase":"PHASE4","title":"A Study to Compare Efficacy and Safety of Zolpidem Modified Release Formulation Versus Zolpidem in Insomnia Patients","status":"COMPLETED","sponsor":"Astellas Pharma Inc","startDate":"2009-10","conditions":"Sleep Initiation and Maintenance Disorders, Primary Insomnia","enrollment":132},{"nctId":"NCT01159652","phase":"PHASE4","title":"Hypnotic Medications and Memory: Effect of Drug Exposure During the Night","status":"COMPLETED","sponsor":"St. Luke's Hospital, Chesterfield, Missouri","startDate":"2010-10","conditions":"Sleep, Memory","enrollment":26},{"nctId":"NCT00283946","phase":"PHASE3","title":"A Double-blind, Group-comparison Study Using Zolpidem (Myslee) as a Comparative Drug in Patients With Insomnia","status":"COMPLETED","sponsor":"Astellas Pharma Inc","startDate":"2006-02","conditions":"Sleep Initiation and Maintenance Disorders, Sleep Disorders","enrollment":876},{"nctId":"NCT00374777","phase":"PHASE3","title":"A Double-blind, Group-comparison P-III Study With Zolpidem MR Using Placebo and Nitrazepam in Insomnia Patients","status":"COMPLETED","sponsor":"Astellas Pharma Inc","startDate":"2006-08","conditions":"Sleep Initiation and Maintenance Disorders","enrollment":450}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":12,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Patz - 5mg sublingual zolpidem hemitartrate","Stilnox - 10mg oral zolpidem hemitartrate"],"phase":"marketed","status":"active","brandName":"Zolpidem Hemitartrate","genericName":"Zolpidem Hemitartrate","companyName":"EMS","companyId":"ems","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Zolpidem hemitartrate is a sedative-hypnotic that binds to GABA-A receptors in the brain to enhance inhibitory neurotransmission and promote sleep onset. Used for Insomnia (short-term treatment of sleep initiation difficulty).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}